The American Journal of Medicine
Volume 69, Issue 6 , Pages 828-832 , December 1980

Pregnancy outcome following cancer chemotherapy

  • Julie Blatt, M.D.

      Affiliations

    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Dr. Julie Blatt, Pediatric Oncology Branch, National Cancer Institute, Bldg. 10, Room 3B12, Bethesda, Maryland 20205.
    • ,
  • John J. Mulvihill, M.D.

      Affiliations

    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • ,
  • John L. Ziegler, M.D.

      Affiliations

    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • ,
  • Robert C. Young, M.D., F.A.C.P.

      Affiliations

    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • ,
  • David G. Poplack, M.D.

      Affiliations

    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205, USA

,Accepted 6 June 1980.

References 

  1. Schein PS, Winokur SH. Immunosuppressive and cytotoxic chemotherapy: Longterm complications. Ann Intern Med. 1975;82:84–95
  2. Langman J. Medical embryology. In: 2nd ed. Baltimore: Williams & Wilkins Co.; 1969;p. 69
  3. Schmidt W, Kreutz R, Wendler D, Gabler W. Development of skeletal abnormalities following administration of aminoacetonitrile and cyclophosphamide during rat fetogenesis. Verh Anat Ges. 1977;71:635–638
  4. Gulluni CM, Santoro DL. Teratogenic effects of L-asparaginase on anuran amphibians. Riv Biol. 1977;70:283–302
  5. Murphy ML, Karnovsky DA. Effect of Azaserine and other growth inhibiting agents on fetal development of the rat. Cancer. 1956;9:955–962
  6. Sieber SM, Whang-Peng J, Botkin C, Knutsen T. Teratogenic and cytogenetic effects of some plant-derived antitumor agents in mice. Teratology. 1978;18:31–47
  7. Bollag VW. Cytostatica in des Scvhwangershaft. Schweiz Med Wochenschr. 1954;84:393–395
  8. Myles TJM. Hodgkin's disease and pregnancy. J Obstet Gynecol. Br Empire. 1955;62:884–891
  9. Lee RA, Johnson CE, Hanlon DG. Leukemia during pregnancy. Am J Obstet Gynecol. 1962;84:455–458
  10. Barry RM, Diamond HD, Craver LF. Influence of pregnancy on course of Hodgkin's disease. Am J Obstet Gynecol. 1962;84:445–454
  11. Hoover BA, Schumacher HR. Acute leukemia in pregnancy. Am J Obstet Gynecol. 1966;96:316–320
  12. Yahia C, Hyman GA, Phillips LL. Acute leukemia in pregnancy. Obstet Gynecol Surv. 1958;13:1–21
  13. Bilski-Pasquier G, Charon P, Brusser J. Leucose et grossesse. Nouv Rev fr Hematol. 1962;2:289–311
  14. Smith RBW, Sheehy TW, Rothberg H. Hodgkin's disease and pregnancy. Arch Intern Med. 1958;102:777–789
  15. Sokal JE, Lessmann EM. Effects of cancer chemotherapeutic agents on human fetus. JAMA. 1960;172:1765–1972
  16. Warkany J. Aminopterin and methotrexate: folic acid deficiency. Teratology. 1978;17:353–357
  17. Howard NJ, Rudd NL. The natural history of aminopterin induced embryopathy. Birth Defects. 1977;13:85–93
  18. Diamond I. Effects of cancer chemotherapeutic agents on human fetus. JAMA. 1960;172:1765–1772
  19. Nicholson HO. Cytotoxic drugs in pregnancy. J Obstet Gynecol Br Comm. 1968;75:307–312
  20. Greenberg LH, Tanaka KR. Congenital anomalies probably induced by cyclophosphamide. JAMA. 1964;188:423–426
  21. Toledo TM, Harper RC, Moses RH. Fetal effects during cyclophosphamide and irradiation therapy. Ann Intern Med. 1971;74:87–91
  22. Salzberger B. Experimental studies on the genesis of limb malformations produced in chicken embryos with nitrogen mustard. Birth Defects. 1977;13:155–177
  23. Symington GR, Mackay IR, Lambert RP. Cancer and teratogenesis: Infrequent occurrence after medical use of immunosuppressive drugs. Aust NZ J Med. 1977;7:368–372
  24. Hardin JS. Cyclophosphamide treatment of lymphoma during third trimester of pregnancy. Obstet Gynecol. 1971;39:850–851
  25. Boros SJ, Reynolds JW. Intrauterine growth retardation following third-trimester exposure to busulfan. Am J Obstet Gynecol. 1977;129:111–112
  26. Ross G. Congenital anomalies among children born of mothers receiving chemotherapy for gestational trophoblastic neoplasms. Cancer. 1976;37:1043–1047
  27. Li FP, Fine W, Jaffe N, Holmes GE, Holmes FF. Offspring of patients treated for cancer in childhood. J Natl Cancer Instit. 1979;62:1193–1197
  28. Li FP, Jaffe N. Progeny of childhood cancer survivors. Lancet. 1974;2:704–714
  29. Maurer LH, Forcier RJ, McIntyre OR, Benirschke K. Fetal group C trisomy after cytosine arabinoside and thioguanine. Ann Intern Med. 1971;75:809–810
  30. Holmes GE, Holmes FF. Pregnancy outcome of patients treated for Hodgkin's disease. Cancer. 1978;41:1317–1322
  31. Lowenthal RM, Marsden KA, Newman NM, Baikie MJ, Campbell SN. Normal infant after treatment of acute myeloid leukemia in pregnancy with daunorubicin. Aust NZ J Med. 1978;8:431–432
  32. Menutti MR, Shepard TH, Mellman WJ. Fetal renal malformations following Hodkgin's disease during pregnancy. Obstet Gynecol. 1975;46:194–199
  33. Lee IP, Dixon RL. Mutagenicity carcinogenicity and teratogenicity of procarbazine. Mutat Res. 1978;55:1–14
  34. Doney KC, Kraemer KG, Shepard TH. Combination chemotherapy for acute myelocytic leukemia during pregnancy: three case reports. Cancer Treat Rep. 1979;63:369–371
  35. McKeen EA, Mulvihill JJ, Rosner F, Zarrah MH. Pregnancy outcome in Hodgkin's disease. Lancet. 1979;2:590
  36. Pritchard JA, MacDonald PC. In: 15th ed. Williams, Obstetrics. New York: D. Appleton-Century Co.; 1976;p. 1003

PII: S0002-9343(80)80007-6

The American Journal of Medicine
Volume 69, Issue 6 , Pages 828-832 , December 1980

Article Tools